These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6412782)

  • 1. [Pharmacology of thyroliberin].
    Zakusov VV; Bulaev VM; Gan'shina TS; Kozhechkin SN; Mirzoian RS
    Biull Eksp Biol Med; 1983 Sep; 96(9):61-4. PubMed ID: 6412782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. L-6-ketopiperidine-2-carbonyl-L-leucyl-L-proline amide as a novel thyrotropin releasing hormone analogue with improving effects on impaired central nervous systems functions.
    Oka M; Ochi Y; Furukawa K; Ito T; Miura Y; Karasawa T; Kadokawa T
    Arzneimittelforschung; 1989 Mar; 39(3):297-303. PubMed ID: 2547386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Role of adrenergic mechanisms in the cerebrovascular effect of thyroliberin].
    Mirzoian RS; Gan'shina TS; Ragimov KhS; Saks TR; Tsvetkov DE
    Farmakol Toksikol; 1985; 48(5):18-22. PubMed ID: 3935482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiepileptic potential and behavioral profile of L-pGlu-(2-propyl)-L-His-L-ProNH2, a newer thyrotropin-releasing hormone analog.
    Rajput SK; Krishnamoorthy S; Pawar C; Kaur N; Monga V; Meena CL; Jain R; Sharma SS
    Epilepsy Behav; 2009 Jan; 14(1):48-53. PubMed ID: 18952198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopaminergic neuronal systems modulate the central cardiovascular effects of TRH in rats.
    Jedrusiak J; Brus R; Kostrzewa RM; Słowiński Z
    Pol J Pharmacol; 1995; 47(1):43-52. PubMed ID: 7550548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pharmacological study of the cardiovascular effects of TRH-T in haemorrhagic shock in rats.
    Guarini S; Gherardi S; Calabrò G; Bertolini A
    Arch Int Pharmacodyn Ther; 1989; 299():65-76. PubMed ID: 2505701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of thyrotropin-releasing hormone and its analogue L-6-ketopiperidine-2-carbonyl-leucyl-L-prolin-amide on behaviour and electroencephalogram.
    Sarkadi A; Szabo S; Laszy J; Ambrus A; Szporny L
    Arzneimittelforschung; 1988 Aug; 38(8):1134-8. PubMed ID: 3143370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular mechanisms of thyrotropin-releasing hormone against experimental hemorrhagic shock.
    Zheng D; Chen HS; Hu DY
    Circ Shock; 1992 Mar; 36(3):169-73. PubMed ID: 1611701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Role of the opioidergic system in regulating respiration].
    Voĭnov VA; Bulaev VM
    Biull Eksp Biol Med; 1983 Oct; 96(10):57-9. PubMed ID: 6414551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of TRH on acoustic startle, conditioned fear and active avoidance in rats.
    Thompson BL; Rosen JB
    Neuropeptides; 2000 Feb; 34(1):38-44. PubMed ID: 10688967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mechanism of the antidepressive and learning-stimulating effects of thyroliberin and its analogs].
    Zakusov VV; Ostrovskaia RU; Kosoĭ MIu; Gudasheva TA; Skoldinov AP
    Biull Eksp Biol Med; 1986 Jul; 102(7):39-41. PubMed ID: 3089346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mediators in the mechanism of the neurotropic action of thyroliberin].
    Zakusov VV
    Biull Eksp Biol Med; 1984 Oct; 98(10):456-7. PubMed ID: 6149777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of VA-045 on disturbance in consciousness in experimental animal models.
    Okuyama S; Imagawa Y; Ogawa S; Saito Y; Araki H; Otomo S; Sakagawa T; Yamada S; Shima K
    Res Commun Chem Pathol Pharmacol; 1993 Oct; 82(1):91-100. PubMed ID: 8272576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of hemorrhagic shock in rats using the metabolically stable thyrotropin-releasing hormone analog taltirelin hydrate.
    Asai H; Watanabe Y; Yamauchi-Kohno R; Doi O
    J Recept Signal Transduct Res; 2011 Dec; 31(6):416-22. PubMed ID: 22044177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the novel thyrotropin-releasing hormone analogue Na -((1S,2R)-2-methyl-4-oxocyclopentylcarbonyl)-L-histidyl-L-prol ina mide monohydrate on the central nervous system in mice and rats.
    Matsushita M; Yonemori F; Furukawa N; Ohta A; Toide K; Uchida I; Iwata K
    Arzneimittelforschung; 1993 Aug; 43(8):813-7. PubMed ID: 8216433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonin and thyrotropin-releasing hormone do not augment their effects on gastric motility on their microinjection into the nucleus raphe obscurus of the rat.
    Krowicki ZK; Hornby PJ
    J Pharmacol Exp Ther; 1995 Apr; 273(1):499-508. PubMed ID: 7714805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of thyroliberin on the central nervous system].
    Aslanov AS; Lavretskaia GI
    Probl Endokrinol (Mosk); 1987; 33(4):51-5. PubMed ID: 3116536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous central histamine-induced reversal of critical hemorrhagic hypotension in rats: studies with L-histidine.
    Jochem J
    Shock; 2003 Oct; 20(4):332-7. PubMed ID: 14501947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biphasic effects of thyrotropin-releasing hormone on exploratory behavior in mice.
    Ushijima I; Yamada K; Furukawa T; Noda Y; Todoroki M; Inanaga K
    Arch Int Pharmacodyn Ther; 1980 Oct; 247(2):257-63. PubMed ID: 6778401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyrotropin releasing hormone: autonomic effects upon cardiorespiratory function in endotoxic shock.
    Holaday JW; Faden AI
    Regul Pept; 1983 Oct; 7(2):111-25. PubMed ID: 6419292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.